Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

about

Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.Staphylococcus aureus in cystic fibrosis: problem bug or an innocent bystander?

P2860

Q47549034-5174E54F-BCD1-4DCA-A262-846658B2B7E6 Q55364460-FF99500F-ADCE-4D45-8CB1-8081B09583F3

P2860

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

Item

http://www.wikidata.org/entity/Q40449041

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Microbiological efficacy of ea ...... a randomised controlled trial.

@en

type

Item

label

Microbiological efficacy of ea ...... a randomised controlled trial.

@en

prefLabel

Microbiological efficacy of ea ...... a randomised controlled trial.

@en

P1476

Microbiological efficacy of ea ...... a randomised controlled trial.

@en

P2093

Arthur Baines

http://www.w3.org/2001/XMLSchema#string

Edith T Zemanick

http://www.w3.org/2001/XMLSchema#string

Elena Popowitch

http://www.w3.org/2001/XMLSchema#string

Jill M VanDalfsen

http://www.w3.org/2001/XMLSchema#string

Marianne Sponer Muhlebach

http://www.w3.org/2001/XMLSchema#string

Melissa B Miller

http://www.w3.org/2001/XMLSchema#string

Nicole Mayer-Hamblett

http://www.w3.org/2001/XMLSchema#string

Preston Campbell

http://www.w3.org/2001/XMLSchema#string

STAR-too study team

http://www.w3.org/2001/XMLSchema#string

Valeria Beckett

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis

A multiple testing procedure for clinical trials

Standardisation of spirometry

Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.

The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers.

Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.

Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients

Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.

P304

318-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAXJNL-2016-208949

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher H Goss

P577

2016-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27852955

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

5489741

http://www.w3.org/2001/XMLSchema#string

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

about

P2860

P2860

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932